IL6 and rheumatoid arthritis: Under RA conditions, FLS undergo epigenetic changes toward an inflammatory phenotype (Neumann et al., 2010) that highly expresses tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-1β and proteases, which fuel further inflammation and destruction of bone (Nygaard and Firestein, 2020).